TimothyCraterMDFACP

Internal Medicine • Winchester, TN

Hospital Medicine/Hospitalist

Internist at Tennova Internal Medicine Harton

Join to view full profile

Dr. Crater is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Crater's full profile

Already have an account?

Office
2118 Cowan Hwy
Winchester, TN 37398
Phone+1 931-962-4040

Summary

I am a Board certified Internist . I completed my residency at UAB. I re-certified in 2011 and 2022.

Education & Training

University of Alabama Medical CenterResidency, Internal Medicine, 1998 - 2001
University of Alabama Medical CenterInternship, Internal Medicine, 1998 - 1999
University of Kansas School of MedicineClass of 1998
Wake Forest UniversityBA, History, Magna cum Laude, 1984 - 1989

Certifications & Licensure

TN State Medical License 2018 - 2026
KS State Medical License 2001 - 2019
AL State Medical License 1998 - 2001
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Diabetes Recognition Program National Committee for Quality Assurance, 2013-2016
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Elected to Fellowship American College of Physicians, 2004
Alpha Omega Alpha Honor Medical Society 1998
Phi Beta Kappa Liberal Arts Honor Society 1989
Join now to see all

Clinical Trials

Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension Start of enrollment: 2012 Jan 01
Completed
Phase 3
Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease Start of enrollment: 2012 Jun 01
Terminated
Phase 3
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Start of enrollment: 2013 Feb 08
Completed
Phase 3
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects Start of enrollment: 2013 Oct 29
Terminated
Phase 3
Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects Start of enrollment: 2014 Sep 10
Completed
Phase 3
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

Combat.
Timothy A Crater
The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha. 2003-01-01

Committees

chair, Clinical Quality at Hutchinson Clinic 2014 - 2016

Professional Memberships

Alpha Omega Alpha Honor Medical Society - AOA
Member
American College of Physicians - ACP
Fellow

External Links

Hutchinson Clinichttp://www.hutchclinic.com